Azitra is trading 9.24% lower at $0.80, with no confirmed company-specific announcement explaining the November 4 decline.
- The latest identified company releases were from October 29 and earlier.
- The decline came as broader markets and the biotech sector gained; available evidence does not establish a specific catalyst or trading-volume pattern.